Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 29, 2022
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
[ Tue, Nov 29th 2022
] - WOPRAI
Marc Goodman Maintained (AXSM) at Buy with Increased Target to $85 on, Nov 29th, 2022
Marc Goodman of SVB Leerink, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $65 to $85 on, Nov 29th, 2022.
Marc has made no other calls on AXSM in the last 4 months.
There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 0 agree with Marc's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Marc
- Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $80 on, Friday, November 11th, 2022
- Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $80 on, Wednesday, November 9th, 2022
- Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
- Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
